# Medicinal Cannabis Use: Clinical Relevance and Emerging Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/clinical-relevance-medicinal-cannabis-use/ > **Published:** 2026-03-29T01:02:29-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:08:00-04:00 > **Clinical Summary:** Explore clinical relevance medicinal cannabis with new research insights highlighting evidence and patient counseling challenges in cannabis medicine. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Evidence-Based Medicine[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)Patient CounselingMedical CannabisClinical Practice Why This Matters With medicinal cannabis adoption accelerating globally, clinicians need evidence-based frameworks to counsel patients appropriately. Without the specific research details, this highlights the ongoing tension between clinical enthusiasm and rigorous evidence standards that should guide therapeutic recommendations. Clinical Summary The headline suggests new research challenges the clinical benefits of medicinal cannabis, though the specific studies and findings are not detailed in the available summary. This reflects the broader evidence landscape where patient-reported benefits often exceed what controlled trials demonstrate. The disconnect between widespread adoption and controlled evidence remains a defining characteristic of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Dr. Caplan’s Take “I see this tension daily in practice — patients experiencing genuine relief while our evidence base remains frustratingly incomplete. The key is honest counseling about what we know, what we don’t, and helping patients make informed decisions within that uncertainty.” Clinical Perspective 🧠 Clinicians should maintain evidence-based skepticism while remaining open to patient experiences. Focus on clear therapeutic goals, monitor outcomes objectively, and adjust expectations based on the strength of evidence for specific conditions. This reinforces the importance of treating [cannabis as medicine](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) — with appropriate clinical oversight. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medicinal%20cannabis%20use%20has%20exploded%2C%20but%20new%20research%20puts%20benefits%20in%20doubt%20-%20L...%20%40drcaplan&url=https%3A//www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medicinal%20cannabis%20use%20has%20exploded%2C%20but%20new%20research%20puts%20benefits%20in%20doubt%20-%20L...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66](https://www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of medical content does this article focus on?](#What_type_of_medical_content_does_this_article_focus_on) - [Who is the target audience for this information?](#Who_is_the_target_audience_for_this_information) - [What does the “Notable Clinical Interest” designation mean?](#What_does_the_8220Notable_Clinical_Interest8221_designation_mean) - [Is this information suitable for patient education?](#Is_this_information_suitable_for_patient_education) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What type of medical content does this article focus on? The article focuses on evidence-based medicine and [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) related to medical cannabis. It appears to be designed for healthcare professionals involved in patient counseling and [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). #### Who is the target audience for this information? This content is primarily targeted at healthcare professionals, particularly those working in clinical settings who need to stay informed about cannabis-related medical developments. The clinical relevance rating and evidence-based approach suggest it’s meant for medical practitioners rather than general consumers. #### What does the “Notable Clinical Interest” designation mean? The “Notable Clinical Interest” designation indicates that this information contains emerging findings or policy developments in the medical cannabis field. Healthcare professionals should pay close attention to these developments as they may impact clinical practice or patient care. #### Is this information suitable for patient education? While the article touches on patient counseling topics, it appears to be primarily designed for healthcare professionals rather than direct patient education. Patients should consult with their healthcare providers to discuss how this information may apply to their specific medical situations. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Medicinal cannabis use has exploded, but new research puts benefits in doubt – LinkedIn”, “url”: “https://www.linkedin.com/posts/dawn-marie-steenstra-99b0bb101_medicinal-cannabis-use-has-exploded-but-activity-7443716642234220544-Ce66”, “datePublished”: “2026-03-28T18:57:38Z”, “about”: “medicinal cannabis use has exploded but”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) This article reviews recent studies indicating limited effectiveness of cannabis for mental health conditions like depression and anxiety. [Read More](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) [Cannabis shows little benefit for most mental disorders – PressReader](https://cedclinic.com/limited-evidence-cannabis-mental-health/) An analysis of cannabis's limited therapeutic benefits across various [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), emphasizing the need for cautious clinical use. [Explore Article](https://cedclinic.com/limited-evidence-cannabis-mental-health/) [Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/) A comprehensive review highlighting the current evidence gaps in cannabis treatment for [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/). [Learn More](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).